comparemela.com

Latest Breaking News On - Bio inc - Page 5 : comparemela.com

Nuvation Bio Inc (NYSE:NUVB) to Post Q2 2025 Earnings of ($0 10) Per Share, HC Wainwright Forecasts

Nuvation Bio Inc. (NYSE:NUVB – Free Report) – Stock analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for Nuvation Bio in a research report issued on Wednesday, May 22nd. HC Wainwright analyst R. Burns anticipates that the company will post earnings per share of ($0.10) for the quarter. HC Wainwright has […]

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor What This Means Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs

GRI Bio (NASDAQ: GRI) Participates in Virtual Investor What This Means Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) Programs
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference

Upstream Bio Presents Results from a Dose Ranging Study of Verekitug (UPB-101) in Adults with Asthma at the American Thoracic Society International Conference
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program

AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Q32 Bio (NASDAQ:QTTB) Earns Outperform Rating from Analysts at SVB Leerink

Research analysts at SVB Leerink initiated coverage on shares of Q32 Bio (NASDAQ:QTTB – Get Free Report) in a note issued to investors on Tuesday, Briefing.com reports. The brokerage set an “outperform” rating and a $54.00 price target on the stock. SVB Leerink’s price objective would indicate a potential upside of 78.81% from the company’s […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.